CN Patent

CN103274961B — 治疗细胞增殖紊乱的化合物和方法

Assigned to Anzix Special Purpose Co ltd · Expires 2016-05-18 · 10y expired

What this patent protects

本发明涉及的是治疗细胞增殖紊乱的化合物和方法。

USPTO Abstract

本发明涉及的是治疗细胞增殖紊乱的化合物和方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN103274961B
Jurisdiction
CN
Classification
—
Expires
2016-05-18
Drug substance claim
No
Drug product claim
No
Assignee
Anzix Special Purpose Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.